Donald J. Vander Griend, Ph.D.
Affiliations: | 2004 | University of Chicago, Chicago, IL |
Area:
Oncology, Molecular BiologyGoogle:
"Donald Vander Griend"Parents
Sign in to add mentorCarrie Rinker-Schaeffer | grad student | 2004 | Chicago | |
(Stress -activated protein kinase pathways and metastasis: The role of MKK4.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vellky JE, Kirkpatrick BJ, Gutgesell LC, et al. (2024) ERBB3 overexpression is enriched in diverse patient populations with castration-sensitive prostate cancer and is associated with a unique AR activity signature. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Rather HA, Almousa S, Kumar A, et al. (2023) The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer. Cancers. 16 |
Bennett L, Jaiswal PK, Harkless RV, et al. (2023) Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer. Molecular Cancer Therapeutics |
Vellky JE, Wu Y, Moline D, et al. (2023) Single-cell RNA sequencing of human prostate basal epithelial cells reveals zone-specific cellular populations and gene expression signatures. The Journal of Pathology |
Williams A, Gutgesell L, de Wet L, et al. (2023) SOX expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis. Cancer Letters. 216209 |
Moline DC, Zenner ML, Burr A, et al. (2022) Single-cell RNA-Seq identifies factors necessary for the regenerative phenotype of prostate luminal epithelial progenitors. American Journal of Clinical and Experimental Urology. 10: 425-439 |
Deng S, Wang C, Wang Y, et al. (2022) Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nature Cancer |
de Wet L, Williams A, Gillard M, et al. (2022) Correction to: SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 41: 1234 |
de Wet L, Williams A, Gillard M, et al. (2022) SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene |
Hintz HM, Gallant JP, Vander Griend DJ, et al. (2020) Imaging Fibroblast Activation Protein Alpha improves diagnosis of metastatic Prostate Cancer with Positron Emission Tomography. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |